Skip to content

Rheumatology Informatics System for Effectiveness

American College of Rheumatology's Rheumatology Informatics System for Effectiveness

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02230943
Acronym
RISE
Enrollment
100000
Registered
2014-09-03
Start date
2014-04-30
Completion date
Unknown
Last updated
2014-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout, Osteoarthritis, Rheumatoid Arthritis

Keywords

rheumatoid, arthritis, osteoarthritis, gout

Brief summary

The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR) and allows for a simplified entry process, while establishing a best-in-class resource to manage your patient population and improve patient care. RISE provides participants with an infrastructure for robust quality improvement activities leading to improved patient outcomes, patient population management and quality reporting related to rheumatic diseases and drug safety. RISE gives physicians and researchers the information they need to optimize patient outcomes, meet reporting requirements, and make discoveries that advance rheumatology.

Detailed description

RISE helps providers benchmark performances on key rheumatology clinical quality measures and align with best practice standards. The RISE benchmarking tool allows providers to view the details of their patient population against established rheumatology quality metrics. RISE allows access to aggregate data from other participating sites so providers can view their patient population in comparison to other RISE participants. RISE is integrated into an electronic health records (EHR) system, bringing a single point of entry into one solution for filing for quality-based incentive payments, avoiding penalties, complying with reporting requirements and tracking caseloads for quality monitoring and improvement initiatives. RISE collects the data needed to meet current federal reporting requirements. Participating in RISE helps push the field of rheumatology practice forward. RISE provides a source of information on patient outcomes and quality care for rheumatology leading to new discoveries, better understanding and a source of comparative effectiveness research.

Interventions

None listed

Sponsors

American College of Rheumatology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients 18 years of age and older with one of the following diagnoses: rheumatoid arthritis, osteoarthritis, gout

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Controlling High Blood Pressureone yearPercentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (\<140/90mmHg) during the measurement period.

Countries

United States

Contacts

Primary ContactMelissa D Francisco
mfrancisco@rheumatology.org404-633-3777
Backup ContactRachel Myslinski, MBA
rmyslinski@rheumatology.org404-633-3777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026